NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BIO INX

BIO INX

Private
BelgiumHealthcare & Life Scienceshttps://bioinx.com/

Last Round

Grant

Jul 4, 2024

Total Funding Raised

$958,000

Company Overview

BIO INX is a biotechnology company that develops and commercializes materials and bio-inks for 3D bioprinting.

Sector

Healthcare & Life Sciences

Verticals

Advanced Materials, 3D Printing, Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bio-inks3D bioprintingbioprinting materialstissue engineeringregenerative medicinebioprinting consumableslive cell printing3D printed tissueshigh-resolution bioprintingdrug screeningGel-MAtissue scaffoldsorgan printingbiodegradable resinsacrificial inkcosmetics screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIO INX Comparables

Compare BIO INX with similar companies based on industry and business-model similarity.

BIO INX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TissueLabs
87%
Axolotl Biosciences
86%
Foldink
85%

BIO INX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 4, 2024
SeedSep 16, 2022

Key People

Founding team and executive leadership

Jasper Van Hoorick

Chief Executive Officer

Executive Team

BIO INX Investors

Notable investors and investment history

BIO INX investors
InvestorRounds
Interreg CrossRoads ProgrammeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2025

    Monthly visitors grew 63% MoM, from 3K to 4.9K.

  • Feb 7, 2025

    Grew 50% QoQ, from 8 to 12 employees.

BIO INX Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BIO INX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BIO INX's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range11
Year Founded2022
Last FundingJul 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.